© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

‘Groundbreaking’ sickle cell disease treatment approved for NHS use in England

Clinical trials find one-time gene therapy exa-cel offers ‘functional cure’ in 96.6% of patients

A “groundbreaking” £1.65m treatment offering a potential cure for people in England living with sickle cell disease has been approved for use on the NHS, the medicines watchdog has announced.

Campaigners welcomed news of the approval of the one-time gene therapy, known as exagamglogene autotemcel, or exa-cel, which edits the faulty gene in a patient’s own stem cells.

Continue reading…

Related posts

MPs defeat bid to save leaseholders from huge fire safety bills

AEA3

Sugary drinks may raise bowel cancer risk, claims major US study

AEA3

Jacinda Ardern wows Harvard with New Zealand’s lesson on gun control and democracy

AEA3

Pin It on Pinterest

Share This